MedTrace Logo

The Grown Up Peanut Immunotherapy Study

NCT03648320 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-05-29

No results posted yet for this study

Summary

To determine efficacy and safety of peanut oral immunotherapy in adults with peanut allergy.

Conditions

Interventions

OTHER

Peanut oral immunotherapy

Daily doses of peanut flour (with 2-weekly incremental interval)

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • King's College London

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • Guy's and St Thomas' NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Stephen J Till, MA FRCP PhD · Guy's and St Thomas' NHS Foundation Trust / King's College London

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2021-05-21
Completion
2022-05-19

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03648320 on ClinicalTrials.gov